Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism
Clinical trial NCT01532414 · COMPLETED
Trial details
- NCT number
- NCT01532414
- Sponsor
- Repros Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2013-03-01
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.